2 Aug 2022 , 03:06 PM
Net profit of Jubilant Pharmova declined 70.70% to Rs 47.04 crore in the quarter ended June 2022 as against Rs 160.56 crore during the previous quarter ended June 2021. Sales declined 10.72% to Rs 1440.47 crore in the quarter ended June 2022 as against Rs 1613.45 crore during the previous quarter ended June 2021.
| Particulars | Quarter Ended | ||
| ? | Jun. 2022 | Jun. 2021 | % Var. |
| Sales | 1440.47 | 1613.45 | -11 |
| OPM % | 13.35 | 22.64 | – |
| PBDT | 163.63 | 334.55 | -51 |
| PBT | 69.06 | 246.51 | -72 |
| NP | 47.04 | 160.56 | -71 |
Powered by Capital Market – Live News
Related Tags

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.